CD274 and neoplasm: As a matter of fact, anti-PD-1 or anti-PDL-1 blocking monoclonal antibodies (mAbs) mediate potent and long-lasting anti-tumor responses in metastatic cutaneous melanoma [282, 283] and other metastatic cancers.